GT Biopharma, Inc.
Institutional Ownership & Holdings Analysis
Company Overview
Key metrics for gt-biopharma
- CIK
- 0000109657
- Entity Type
- Public Company
- Institutional Holders
- 22
- Top 10 Own
- 99.9%
- Total Value Held by Institutions
- $4.2B
Top Institutional Holders
# | Institution | Value |
---|---|---|
1 | DekaBank Deutsche Girozentrale(2024-12-31) | $3.9M |
2 | GEODE CAPITAL MANAGEMENT, LLC(2025-03-31) | $51.7K |
3 | CITADEL ADVISORS LLC(2025-03-31) | $45.1K |
4 | BANK OF MONTREAL /CAN/(2025-03-31) | $32.8K |
5 | VANGUARD GROUP INC(2025-03-31) | $23.5K |
6 | WELLS FARGO & COMPANY/MN(2025-03-31) | $21.5K |
7 | BlackRock, Inc.(2025-03-31) | $20.9K |
8 | MORGAN STANLEY(2025-03-31) | $7.6K |
9 | OSAIC HOLDINGS, INC.(2025-03-31) | $5.8K |
10 | UBS Group AG(2025-03-31) | $5.5K |
11 | Newbridge Financial Services Group, Inc.(2025-03-31) | $3.8K |
12 | Tower Research Capital LLC (TRC)(2025-03-31) | $2.0K |
13 | GHP Investment Advisors, Inc.(2025-03-31) | $71 |
14 | BANK OF AMERICA CORP /DE/(2025-03-31) | $59 |
15 | BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC(2025-03-31) | $22 |
16 | SBI Securities Co., Ltd.(2025-03-31) | $17 |
17 | Farther Finance Advisors, LLC(2025-03-31) | $14 |
18 | BNP PARIBAS FINANCIAL MARKETS(2025-03-31) | $13 |
19 | Allworth Financial LP(2025-03-31) | $3 |
20 | JPMORGAN CHASE & CO(2025-03-31) | $2 |
As of 2024-12-31
Value:$3.9M
As of 2025-03-31
Value:$51.7K
As of 2025-03-31
Value:$45.1K
As of 2025-03-31
Value:$32.8K
As of 2025-03-31
Value:$23.5K
As of 2025-03-31
Value:$21.5K
As of 2025-03-31
Value:$20.9K
As of 2025-03-31
Value:$7.6K
As of 2025-03-31
Value:$5.8K
#10UBS Group AG
As of 2025-03-31
Value:$5.5K
As of 2025-03-31
Value:$3.8K
As of 2025-03-31
Value:$2.0K
As of 2025-03-31
Value:$71
As of 2025-03-31
Value:$59
As of 2025-03-31
Value:$22
As of 2025-03-31
Value:$17
As of 2025-03-31
Value:$14
As of 2025-03-31
Value:$13
As of 2025-03-31
Value:$3
As of 2025-03-31
Value:$2
Total Institutional Holders:22
Top 10 Holders Own:99.9%